4.0
Apr 25, 2024
Current employee, more than 1 year
Princeton, NJ
Recommend
CEO approval
Business Outlook
Pros
Heavy investment in drug discovery and clinical trials for breakthrough contrast agents
Cons
Very competitive landscape competing against very large companies like Bayer and GE